190 related articles for article (PubMed ID: 6578293)
1. Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies.
Adelman NE; Watling DL; McDevitt HO
J Exp Med; 1983 Oct; 158(4):1350-5. PubMed ID: 6578293
[TBL] [Abstract][Full Text] [Related]
2. Dissection of the effects of tumor necrosis factor-alpha and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE).
Fujimura T; Hirose S; Jiang Y; Kodera S; Ohmuro H; Zhang D; Hamano Y; Ishida H; Furukawa S; Shirai T
Int Immunol; 1998 Oct; 10(10):1467-72. PubMed ID: 9796913
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
[TBL] [Abstract][Full Text] [Related]
4. Dissection of the role of MHC class II A and E genes in autoimmune susceptibility in murine lupus models with intragenic recombination.
Zhang D; Fujio K; Jiang Y; Zhao J; Tada N; Sudo K; Tsurui H; Nakamura K; Yamamoto K; Nishimura H; Shira T; Hirose S
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13838-43. PubMed ID: 15361580
[TBL] [Abstract][Full Text] [Related]
5. In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon.
Jacob CO; van der Meide PH; McDevitt HO
J Exp Med; 1987 Sep; 166(3):798-803. PubMed ID: 3114409
[TBL] [Abstract][Full Text] [Related]
6. The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice.
Kotzin BL; Palmer E
J Exp Med; 1987 May; 165(5):1237-51. PubMed ID: 3494806
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of the imperfect association of H-2 haplotype with lupus-like autoimmune disease.
Babcock SK; Appel VB; Schiff M; Palmer E; Kotzin BL
Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7552-5. PubMed ID: 2571993
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the gene linked to the T cell receptor beta chain gene complex of NZW mice to the autoimmunity of (NZB x NZW)F1 mice.
Hirose S; Tokushige K; Kinoshita K; Nozawa S; Saito J; Nishimura H; Shirai T
Eur J Immunol; 1991 Mar; 21(3):823-6. PubMed ID: 1826267
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.
Wang Y; Hu Q; Madri JA; Rollins SA; Chodera A; Matis LA
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8563-8. PubMed ID: 8710910
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous autoimmune disease in (NZB x NZW)F1 mice is ameliorated by treatment with methimazole.
Mozes E; Zinger H; Kohn LD; Singer DS
J Clin Immunol; 1998 Mar; 18(2):106-13. PubMed ID: 9533654
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice.
Carlsten H; Holmdahl R; Tarkowski A
Immunology; 1991 Jun; 73(2):186-90. PubMed ID: 2071164
[TBL] [Abstract][Full Text] [Related]
13. Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW)F1 hybrids.
al-Balaghi S; Möller E; Möller G; Abedi-Valugerdi M
Eur J Immunol; 1996 Jul; 26(7):1519-26. PubMed ID: 8766555
[TBL] [Abstract][Full Text] [Related]
14. Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease.
Maruyama N; Furukawa F; Nakai Y; Sasaki Y; Ohta K; Ozaki S; Hirose S; Shirai T
J Immunol; 1983 Feb; 130(2):740-6. PubMed ID: 6217253
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner.
Drake CG; Rozzo SJ; Hirschfeld HF; Smarnworawong NP; Palmer E; Kotzin BL
J Immunol; 1995 Mar; 154(5):2441-7. PubMed ID: 7868910
[TBL] [Abstract][Full Text] [Related]
16. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4.
Wofsy D; Seaman WE
J Immunol; 1987 May; 138(10):3247-53. PubMed ID: 3106478
[TBL] [Abstract][Full Text] [Related]
17. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.
Wofsy D; Seaman WE
J Exp Med; 1985 Feb; 161(2):378-91. PubMed ID: 3919141
[TBL] [Abstract][Full Text] [Related]
19. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis.
Ozmen L; Roman D; Fountoulakis M; Schmid G; Ryffel B; Garotta G
Eur J Immunol; 1995 Jan; 25(1):6-12. PubMed ID: 7843255
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of systemic lupus erythematosus--studies using disease models. 1. The effect of MHC on lupus nephritis in (NZB x NZW)F1--a therapeutic suggestion].
Sato H; Hirose S; Shirai S
Nihon Rinsho; 1984 Dec; 42(12):2791-5. PubMed ID: 6530763
[No Abstract] [Full Text] [Related]
[Next] [New Search]
